BioVentures Board

The BioVentures Board comprises a select group of individuals from the realms of business, education, philanthropy and the investment community. The Board advises BioVentures on policies and practices to facility basic, medical, clinical and translational research, the development of the information, products and processes resulting from such research, and the investment and management of assets to meet priority needs of UAMS and BioVentures.

Steve Abell
Retired Vice President of Strategic Innovations and Investments
Arkansas Blue Cross and Blue Shield
and Executive Vice President of USAble Corporation

Remi Barbier, MBA
President & CEO
Cassava Sciences

Louise Epstein, MBA
Principal Advisor
LARTA Institute

Amanda George, MHSA, CPA
UAMS Ex Officio Member
Vice Chancellor for Finance and Chief Financial Officer
University of Arkansas for Medical Sciences

Kevin Heyeck
Venture Partner
6 Dimensions Capital

Shuk-Mei Ho, PhD
UAMS Ex Officio Member
Vice Chancellor for Research
University of Arkansas for Medical Sciences

Bobby Sandage, PhD
General Partner
Cultivation Capital Life Sciences

Kevin Sexton, MD
UAMS Ex Officio Member
Interim President, BioVentures, LLC
Trauma Surgeon
Associate Director Healthcare Analytics, Institute for Digital Health & Innovation
Associate Chief Clinical Informatics Officer for Innovation, Research, and Entrepreneurship
Associate Chief Medical Officer
Associate Professor, Department of Surgery
University of Arkansas for Medical Sciences